Articles On LBT Innovations (ASX:LBT)

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

For most medical device companies, selling six instruments within the space of six months would hardly be cause for celebration. But for the Adelaide-based LBT Innovations (ASX:LBT), the sales “inflexion point” was an excuse to crack open a...

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Are you the cuddly type?...

The interest rate rise came and the markets fell, then turned a corner. The question now is — will the wheels stay on? Already lagging, the ASX Emerging Companies (XEC) index has closed 0.8% lower. The benchmark has closed 0.4% behind. The...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

The ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as a few battery metal small caps locked in the right prices from a government ready to pay. The ASX200 has also risen a further 1.1% driven b...

LBT Innovations’ (LBT) wholly owned subsidiary Clever Culture Systems (CCS) receives purchase orders for five APAS Independence instruments from its US-based distributor Thermo Fisher Scientific It comes after LBT acquired the remainder of...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

ShareCafeWebinar Recap – TNR, LBT, 1AD & LIT Catch up on the full webinar with presentations from Torian Resources (ASX: TNR), LBT Innovations (ASX: LBT),  Adalta (ASX: 1AD) & Lithium Australia (ASX: LIT) Webinar Recap – TNR...

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – CEO & Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – We...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

LBT Innovations (LBT) completes the acquisition of Clever Culture Systems (CCS) and now owns 100 per cent On December 29, the company signed a binding agreement with Hettich to acquire its 50 per cent holding in CCS The acquisition consi...

The ASX 200 Health Index (XHJ) is trading higher by 0.30% at the time of writing, compared to the broader index which is also up by 0.87%. Imugene (ASX:IMU) is up by 8% this morning, after confirming that its immunotherapy candidate, PD1-Va...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

LBT Innovations (LBT) signs a binding agreement with Hettich to acquire 50 per cent of Clever Culture Systems (CCS), giving it full ownership The company will pay Hettich $4 million which will be split into $1 million in cash, 30.66 millio...

S&P 500 hovers at record high as COVID-19 cases soar Wall Street closed out a choppy trading session on Tuesday, as the S&P 500 broke a four-day winning streak and closed within a whisker of its all-time high. The S&P 500 index...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Highlights AI has the potential to deliver over AU$20 trillion to the global economy by 2030. AI is making progress in fields like healthcare, mining, sales etc. AI Technology presents vast opportunities for people as well as business...

After a positive Monday to Thursday, the ASX wiped out gains made across the week, losing more than 1% today The ASX followed a plunge on Wall Street with the ASX 200 closing at 7,324, which was 1.44% lower than yesterday’s close. While Wal...

LBT Innovations (LBT) is granted FDA clearance for its culture plate reading technology, APAS Independence The clearance enables both the urine and MRSA analysis modules to be sold commercially to customers in the United States The company...

The ASX failed to replicate yesterday’s positive start to the week, falling over 1% today. The ASX 200 closed 1.47% down at 7,726 points while the ASX Emerging Companies Index fell 0.73% closing at 2,537 points. The worst sectors were healt...

The LBT Innovations Limited (ASX: LBT) share price is deep in the red today. This comes regardless of the medical technology company providing investors with a positive update yesterday. At the time of writing, LBT Innovations shares are d...

ADELAIDE, Australia, Sept. 27, 2021 /PRNewswire/ — Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to anno...

Highlights Artificial intelligence (AI) forms a part of emerging technologies that are expected to shape the future in the upcoming years. The COVID-19 pandemic pushed a significant growth in the AI adoption by many companies. LBT,...

ShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT I...

ShareCafeDisrupting the clinical microbiology market through AI Brent Barnes – CEO and Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. Disrupting the clinical micr...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Highlights  ASX-listed healthcare companies rarely fail to bring joy to the market participants, with a few of them providing outstanding returns in the last couple of months. Rhinomed, IDT Australia, and Prescient lead the way with ou...

Another red day for the ASX to close out the week. The ASX 200 closed 0.05% down from yesterday at 7,461 points, 2.2% lower than a week ago. The ASX Emerging Companies Index meanwhile dropped 2.09%, closing at 2,187 points which is over 5%...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Closing Bell is Stockhead’s daily recap of the trading day on the ASX covering the overall direction of the market, biggest winners and losers as well as other news you might’ve missed during the trading day. Today, ASX shareholders were ta...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

A series of ASX announcements has attracted investors to the biotech sector today, lifting the share prices of some of its players. The buying frenzy has also lifted the broader health sector by as high as 1 per cent earlier today, but is c...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

Australia’s digital and technology sector got a major boost in last night’s Federal Budget, with the government announcing a total of $1.2 billion spending for the whole sector. Part of that, or around 10 per cent, will be used to support t...

ShareCafeHidden Gems Webinar Recap – DNR Capital, 1AG, LBT, PLT, NVU  Catch up on the full webinar with a keynote presentation from DNR Capital & presentations from Alterra Limited (ASX:1AG), LBT innovations (ASX:LBT) , Plenti Group Li...

ShareCafeLBT Innovations (ASX:LBT) – Hidden Gems Webinar Presentation Presenter – Brent Barnes – CEO & Managing Director – ​LBT Innovations is a designer of advanced technology solutions for the medical industry. The company specialize...